M. Eber

934 total citations
24 papers, 793 citations indexed

About

M. Eber is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, M. Eber has authored 24 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in M. Eber's work include Protease and Inhibitor Mechanisms (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Immune Cell Function and Interaction (2 papers). M. Eber is often cited by papers focused on Protease and Inhibitor Mechanisms (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Immune Cell Function and Interaction (2 papers). M. Eber collaborates with scholars based in France, United States and Switzerland. M. Eber's co-authors include Joseph Abecassis, R Millon, G. Bronner, A Engelmann, G Méthlin, H. Flesch, D Müller, Danièle Muller, Richard Breathnach and P Dumont and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and International Journal of Cancer.

In The Last Decade

M. Eber

24 papers receiving 764 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M. Eber 420 356 265 160 125 24 793
L. G. Bobrow 417 1.0× 294 0.8× 307 1.2× 108 0.7× 89 0.7× 13 708
Hiroshi Sato 497 1.2× 420 1.2× 284 1.1× 128 0.8× 94 0.8× 15 828
Fumihiko Matsuno 345 0.8× 226 0.6× 590 2.2× 102 0.6× 127 1.0× 31 986
Taketoshi Shimada 443 1.1× 381 1.1× 313 1.2× 82 0.5× 196 1.6× 40 918
H J Vloedgraven 557 1.3× 312 0.9× 244 0.9× 165 1.0× 59 0.5× 10 837
MS Wicha 346 0.8× 136 0.4× 289 1.1× 93 0.6× 91 0.7× 9 639
Rosemarie Chirco 237 0.6× 320 0.9× 310 1.2× 117 0.7× 91 0.7× 4 662
Michelle D. Martin 499 1.2× 375 1.1× 348 1.3× 114 0.7× 63 0.5× 14 796
Radislav Sedlacek 329 0.8× 480 1.3× 268 1.0× 115 0.7× 44 0.4× 20 713
Lisa M. Bafetti 234 0.6× 348 1.0× 325 1.2× 235 1.5× 81 0.6× 10 674

Countries citing papers authored by M. Eber

Since Specialization
Citations

This map shows the geographic impact of M. Eber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Eber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Eber more than expected).

Fields of papers citing papers by M. Eber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Eber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Eber. The network helps show where M. Eber may publish in the future.

Co-authorship network of co-authors of M. Eber

This figure shows the co-authorship network connecting the top 25 collaborators of M. Eber. A scholar is included among the top collaborators of M. Eber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Eber. M. Eber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burnouf, Thierry, M. Eber, Daniel Kientz, Jean‐Pierre Cazenave, & Thomas Burkhardt. (2004). Assessment of complement activation during membrane‐based plasmapheresis procedures. Journal of Clinical Apheresis. 19(3). 142–147. 14 indexed citations
2.
Lapouge, Gaëlle, R Millon, David W.M. Muller, et al.. (2004). Cisplatin-induced genes as potential markers for thyroid cancer. Cellular and Molecular Life Sciences. 62(1). 53–64. 18 indexed citations
4.
Cutuli, B., et al.. (1998). P5 Hypothyroïdie sévère après chimioradiothérapie d'un cancer du sein. Analyse de quatre cas. Cancer/Radiothérapie. 2(5). 486–487. 1 indexed citations
5.
Müller, D, R Millon, Michel Velten, et al.. (1997). Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: Correlation with clinical outcome. European Journal of Cancer. 33(13). 2203–2210. 52 indexed citations
6.
Millon, R, A Engelmann, G. Bronner, et al.. (1994). Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. European Journal of Cancer Part B Oral Oncology. 30(2). 113–120. 74 indexed citations
7.
Muller, Danièle, C Wolf, Joseph Abecassis, et al.. (1993). Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.. PubMed. 53(1). 165–9. 189 indexed citations
8.
Faradji, A., A. Bohbot, N Roeslin, et al.. (1991). Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effects. Cancer Immunology Immunotherapy. 33(5). 319–326. 52 indexed citations
9.
Müller, D, Richard Breathnach, A Engelmann, et al.. (1991). Expression of collagenase‐related metalloproteinase genes in human lung or head and neck tumours. International Journal of Cancer. 48(4). 550–556. 189 indexed citations
10.
Faradji, A., A. Bohbot, Heiner Frost, et al.. (1991). Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis.. Journal of Clinical Oncology. 9(7). 1251–1260. 48 indexed citations
11.
Faradji, A., A. Bohbot, Serge Dumont, et al.. (1991). Apheresis-Elutriation Program for Adoptive Immunotherapy with Autologous Activated Monocytes in Cancer Patients. The International Journal of Artificial Organs. 14(5). 304–312. 15 indexed citations
12.
Dufour, P, et al.. (1990). Cisplatin-induced anemia. Anti-Cancer Drugs. 1(1). 49–54. 6 indexed citations
13.
Millon, R, et al.. (1989). Modulation of human breast cancer cell adhesion by estrogens and antiestrogens. Clinical & Experimental Metastasis. 7(4). 405–415. 17 indexed citations
14.
Pauli, G., et al.. (1989). Platelet function: Aggregation by PAF or sequestration in lung is not modified during immediate or late allergen-induced bronchospasm in man. Journal of Allergy and Clinical Immunology. 83(5). 990–996. 18 indexed citations
15.
Muller, Delphine, et al.. (1987). Characterization of cell types in human breast tumor primary cultures. Biology of the Cell. 61(1-2). 91–99. 3 indexed citations
16.
Abecassis, Joseph, C Klein-Soyer, Alain Beretz, et al.. (1987). Adhesion of human breast cancer cell line MCF‐7 to human vascular endothelial cells in culture. enhancement by activated platelets. International Journal of Cancer. 40(4). 525–531. 30 indexed citations
17.
Schohn, D., et al.. (1986). Biocompatibility and Hemodynamic Studies during Polycarbonate versus Cuprophane Membrane Dialysis. Blood Purification. 4(1-3). 102–111. 7 indexed citations
18.
Faradji, A., M. Eber, G. Hauptmann, et al.. (1986). An in vitro study of the interactions of plasma proteins with protein A-sepharose CL4B chromatography columns used to remove immunoglobulin G from human plasma.. PubMed. 9(2). 119–26. 2 indexed citations
19.
Eber, M., et al.. (1985). [Left intraventricular thrombosis. From diagnosis to treatment].. PubMed. 34(2). 83–7. 1 indexed citations
20.
Eber, M., et al.. (1980). Immunoradiometric assay for human thyroglobulin and variations in thyroid pathology. Clinica Chimica Acta. 105(1). 51–58. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026